Ravulizumab in Adult Participants With Paroxysmal Nocturnal Hemoglobinuria Currently Treated With High-Dose Eculizumab
- Status
- COMPLETED
- Phase
- PHASE4
Clinical Trials Related to Eculizumab
Related studies linked through entity extraction aliases.
Eculizumab (Soliris) in Covid-19 Infected Patients
- Status
- AVAILABLE
- Phase
- N/A
A Study of the Safety and Activity of Eculizumab in Pediatric Participants With Relapsing Neuromyelitis Optica Spectrum Disorder
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
The Use of Eculizumab in HELLP Syndrome
- Status
- COMPLETED
- Phase
- PHASE1
A Study Evaluating the Efficacy and Safety of ABP 959 Compared With Eculizumab in Adult Participants With PNH
- Status
- COMPLETED
- Phase
- PHASE3
A Phase 3 Open-Label Study of Eculizumab in Pediatric Participants With Refractory Generalized Myasthenia Gravis (gMG)
- Status
- COMPLETED
- Phase
- PHASE3
Pharmacokinetic, Safety, Tolerability, Immunogenicity, and Pharmacodynamic Study of SB12 in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Eculizumab to Treat Thrombotic Microangiopathy/Atypical Hemolytic Uremic Syndrome -Associated Multiple Organ Dysfunction Syndrome in Hematopoietic Stem Cell Transplant Recipients
- Status
- COMPLETED
- Phase
- PHASE2
Study of Danicopan in Participants With Paroxysmal Nocturnal Hemoglobinuria With Inadequate Response to Eculizumab
- Status
- COMPLETED
- Phase
- PHASE2
Pilot Trial of Eculizumab Therapy to Reduce Preservation Injury in Human Macrosteatotic Liver Transplantation
- Status
- WITHDRAWN
- Phase
- EARLY_PHASE1
ALXN1210 Versus Eculizumab in Adult Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) Currently Treated With Eculizumab
- Status
- COMPLETED
- Phase
- PHASE3
ALXN1210 (Ravulizumab) Versus Eculizumab in Complement Inhibitor Treatment-Naïve Adult Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH)
- Status
- COMPLETED
- Phase
- PHASE3
Complement Inhibitor Eculizumab in Clinical Islet Transplantation
- Status
- COMPLETED
- Phase
- PHASE2
Identification and Treatment of Thrombotic Microangiopathies in Allogeneic Stem Cell Transplants
- Status
- COMPLETED
- Phase
- N/A
Study Assessing an Algorithm-based Strategy of Eculizumab Discontinuation in Children and Adults With aHUS
- Status
- COMPLETED
- Phase
- PHASE4
JET-GBS - Japanese Eculizumab Trial for GBS
- Status
- COMPLETED
- Phase
- PHASE2
Extension Study of ECU-MG-301 to Evaluate Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis
- Status
- COMPLETED
- Phase
- PHASE3
Complement Inhibition Using Eculizumab to Overcome Platelet Transfusion Refractoriness in Patients With Severe Thrombocytopenia
- Status
- COMPLETED
- Phase
- PHASE2
Eculizumab in Shiga-toxin Related Hemolytic and Uremic Syndrome Pediatric Patients - ECULISHU
- Status
- COMPLETED
- Phase
- PHASE3
Prevention of Delayed Graft Function Using Eculizumab Therapy (PROTECT Study)
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3